(Q58414438)
Statements
A phase 2 clinical study of SU5416 in patients with refractory acute myeloid leukemia (English)
Franco Cavalli
Walter Fiedler
Rolf Mesters
Heike Tinnefeld
Sonja Loges
Peter Staib
Ulrich Duhrsen
Michael Flasshove
Wolfram Jung
Rolf Kuse
Joerg Thomalla
Hubert Serve
Anne M O'Farrell
Mark Jacobs
Nicoletta M Brega
Paul Scigalla
Dieter K Hossfeld
Wolfgang E Berdel